Vertex Pharmaceuticals Incorporated (0QZU.L) Stock Price

$444.4 0.2%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    7
  • Fundamental

    6
  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Vertex Pharmaceuticals Incorporated, AI stock picks, stock alerts and much more.

Sign up

0QZU.L AI Stock Analysis

AI stock analysis for 0QZU.L is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Vertex Pharmaceuticals Incorporated (0QZU.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Vertex Pharmaceuticals Incorporated (0QZU.L) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Vertex Pharmaceuticals Incorporated (0QZU.L), currently trading at $444.4, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About 0QZU.L

LSE
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis.

  • Symbol

    0QZU.L

  • Market

    LSE

  • Industry

    Medical - Pharmaceuticals

  • Market Cap

    114.1B

0QZU.L Alternative Data

Web Traffic

Vertex Pharmaceuticals Incorporated receives an estimated 273710 monthly visitors to vrtx.com.

  • Web Traffic

    273710

  • Change from Previous Month

    10%

  • 3 Month Change

    20%

  • YoY Change

    20%

Twitter Followers

Vertex Pharmaceuticals Incorporated has 70,775 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    70775

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

Facebook Engagement

Vertex Pharmaceuticals Incorporated has engaged 3,019 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    3019

  • Daily Change

    10.7%

  • 1 Month Change

    6.9%

  • 3 Month Change

    70.6%

  • YoY Change

    70.6%

Instagram Followers

Vertex Pharmaceuticals Incorporated has 12,472 Instagram Followers on its main Instagram account, up by 4.9% over the last month.

  • Instagram Followers

    12472

  • Daily Change

    0%

  • 1 Month Change

    4.9%

  • 3 Month Change

    8.1%

Youtube Subscribers

Vertex Pharmaceuticals Incorporated has 2,750 subscribers on its main Youtube channel, up by 3% over the last month.

  • Youtube Subscribers

    2750

  • Daily Change

    0%

  • 1 Month Change

    3%

  • 3 Month Change

    8.7%

  • YoY Change

    8.7%

Job Postings

Vertex Pharmaceuticals Incorporated has an estimated 185 open job postings, which is down -8.4% over the last month.

  • Job Postings

    185

  • Daily Change

    1.1%

  • 1 Month Change

    8.4%

  • 3 Month Change

    18.9%

  • YoY Change

    18.9%

Reddit Mentions

Vertex Pharmaceuticals Incorporated has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Followers

463,977 are following Vertex Pharmaceuticals Incorporated on LinkedIn, up by 2.4% over the last month.

  • LinkedIn Followers

    463977

  • Daily Change

    2.4%

  • 1 Month Change

    2.4%

  • 3 Month Change

    7.2%

  • YoY Change

    7.2%

Business Outlook

According to employee reviews, the business outlook among employees at Vertex Pharmaceuticals Incorporated is 89 out of 100 (very bullish).

  • Business Outlook

    89

  • Change from Previous Month

    0%

  • 3 Month Change

    1.1%

  • YoY Change

    1.1%

LinkedIn Employees

According to LinkedIn, Vertex Pharmaceuticals Incorporated has 5,940 employees, up by 1.2% over the last month.

  • LinkedIn Employees

    5940

  • Daily Change

    1.2%

  • 1 Month Change

    1.2%

  • 3 Month Change

    2%

  • YoY Change

    2%

News Mentions

Vertex Pharmaceuticals Incorporated was mentioned 2 times in the news yesterday.

  • News Mentions

    2

  • Daily Change

    33.3%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

0QZU.L Financials

0QZU.L Key Metrics
  • Total Revenue

    $2.8B

  • Net Income

    $646.3M

  • Earnings per Share

    $2.52

  • Free cash flow

    $778.2M

  • EBITDA

    $781.8M

  • EBITDA Ratio

    0.282218

  • Total Assets

    $22.9B

0QZU.L 2-year Revenue & Income
0QZU.L 2-year Free Cash Flow

0QZU.L Technicals

0QZU.L SMA
0QZU.L RSI

FAQ

What's the current price of Vertex Pharmaceuticals Incorporated (0QZU.L) Stock?
The price of an Vertex Pharmaceuticals Incorporated (0QZU.L) share is $444.4.

What's the market cap of Vertex Pharmaceuticals Incorporated?
The current market cap of Vertex Pharmaceuticals Incorporated is 114.1B.

Should I buy or sell 0QZU.L?
Multiple alternative data signals suggest that Vertex Pharmaceuticals Incorporated stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Vertex Pharmaceuticals Incorporated a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Vertex Pharmaceuticals Incorporated stock. The bullish indicators suggest that Vertex Pharmaceuticals Incorporated's growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Vertex Pharmaceuticals Incorporated (0QZU.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Vertex Pharmaceuticals Incorporated stock, given the bullish outlook.

What are some stocks similar to Vertex Pharmaceuticals Incorporated (0QZU.L) that investors often compare it to?
Vertex Pharmaceuticals Incorporated (0QZU.L) is often compared to similar stocks such as Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc., Walgreens Boots Alliance and Esperion Therapeutics.

What is the forecast for Vertex Pharmaceuticals Incorporated's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Vertex Pharmaceuticals Incorporated's stock price to be around $469 in 2026. Starting from the current price of $444.4, this represents a 5.5% change in price, indicating a bullish outlook for the stock.

How to buy Vertex Pharmaceuticals Incorporated (0QZU.L) Stock?
Vertex Pharmaceuticals Incorporated stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Vertex Pharmaceuticals Incorporated shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.